4-Amino-3-(p-chlorphenyl)1-methylpyrazolo<3,4-d>pyrimidin | 58791-75-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-Amino-3-(p-chlorphenyl)1-methylpyrazolo<3,4-d>pyrimidin
• 英文别名: 3-(4-chloro-phenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine；4-Amino-3-[p-chlorophenyl]-1-methylpyrazolo[3,4-d]pyrimidine；3-(4-chlorophenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine
• CAS: 58791-75-6
• 化学式: C₁₂H₁₀ClN₅
• 分子量: 259.698
• InChiKey: JNUSLASCIZFOAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  69.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-氨基吡唑并[3,4-d]嘧啶 在 tris(dibenzylideneacetone)dipalladium(0) chloroform complex 、 N-碘代丁二酰亚胺 、 偶氮二甲酸二异丙酯 、 caesium carbonate 、 三苯基膦 、 1,3,5,7-四甲基-6-苯基-2,4,8-三氧杂-6-磷酰金刚烷 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 1.84h， 生成 4-Amino-3-(p-chlorphenyl)1-methylpyrazolo<3,4-d>pyrimidin
  参考文献：
  名称：

  Microwave-assisted synthesis of N1- and C3-substituted pyrazolo[3,4-d]pyrimidine libraries

  摘要：

  The parallel synthesis of a library N1- and C3-substituted-pyrazolo[3,4-d]pyrimidines is described. The microwave-assisted approach involves the de novo generation of the heterocyclic scaffold, facile alkylation at N1 via either a Mitsunobu or a direct alkylation reaction and arylation at C3 via a Suzuki reaction. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2011.08.103

文献信息

• MODULATION OF PROTEIN TRAFFICKING
  申请人：Bulawa Christine Ellen

  公开号：US20100331297A1

  公开（公告）日：2010-12-30

  Compounds and compositions are provided for treatment or amelioration of one or more disorders characterized by defects in protein trafficking. A method of treating a disorder characterized by impaired protein trafficking includes administering to a subject or contacting a cell with a compound of Formula I: [formula here] or pharmaceutically acceptable salts or derivatives thereof.

  本发明提供用于治疗或改善由蛋白质运输缺陷所特征的一个或多个疾病的化合物和组合物。一种治疗由蛋白质运输受损所特征的疾病的方法包括向受试者施用或与细胞接触化合物I的药物或其药学上可接受的盐或衍生物。[公式在此]
• 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions
  申请人：SABILA BIOSCIENCES LLC

  公开号：US10844038B2

  公开（公告）日：2020-11-24

  This invention provides compounds of the formula (I): wherein Y1, Y2, Z, X1, X2, and W′ are defined in the specification. These compounds are useful in the treatment of tyrosine kinases, MAPK signaling pathway kinases and PI3K/AKT/mTor signaling pathway kinases-mediated diseases or conditions, such as neurodegeneration, neuroprotection, cancer, autoimmune as well as other diseases and conditions associated with the modulation of tyrosine kinases selected from FYN, FYN Y531F, FLT3, FLT3-ITD, BRK, ITK, FRK, BTK, BMX, SRC, FGR, YES1, LCK, HCK, RET, CSK, LYN, and ROS1; MAPK pathway kinases selected from ARAF, BRAF, CRAF, ERK1/2, MEK1, MEK2, MEK3, MEK4, MEK5, MEK6, and MEK7; and PI3K/AKT/mTor pathway kinases: selected from mTor, PI3K α, PI3K β, PI3K γ, and PI3K δ.

  本发明提供了式 (I) 的化合物： 其中Y1、Y2、Z、X1、X2和W′在说明书中定义。这些化合物可用于治疗酪氨酸激酶、MAPK 信号通路激酶和 PI3K/AKT/mTor 信号通路激酶介导的疾病或病症，如神经变性、神经保护、癌症、自身免疫以及与酪氨酸激酶调节有关的其他疾病和病症、以及其他与酪氨酸激酶调节相关的疾病和病症，这些酪氨酸激酶选自 FYN、FYN Y531F、FLT3、FLT3-ITD、BRK、ITK、FRK、BTK、BMX、SRC、FGR、YES1、LCK、HCK、RET、CSK、LYN 和 ROS1；MAPK 通路激酶，选自 ARAF、BRAF、CRAF、ERK1/2、MEK1、MEK2、MEK3、MEK4、MEK5、MEK6 和 MEK7；以及 PI3K/AKT/mTor 通路激酶：选自 mTor、PI3K α、PI3K β、PI3K γ 和 PI3K δ。
• SOUTHWICK P. L.; DHAWAN B., J. HETEROCYCL. CHEM. <JHTC-AD>, 1975, 12, NO 6, 1199-1205
  作者：SOUTHWICK P. L.、 DHAWAN B.

  DOI：——

  日期：——
• Microwave-assisted synthesis of N1- and C3-substituted pyrazolo[3,4-d]pyrimidine libraries
  作者：Nick Todorovic、Emelia Awuah、Tushar Shakya、Gerard D. Wright、Alfredo Capretta

  DOI：10.1016/j.tetlet.2011.08.103

  日期：2011.11

  The parallel synthesis of a library N1- and C3-substituted-pyrazolo[3,4-d]pyrimidines is described. The microwave-assisted approach involves the de novo generation of the heterocyclic scaffold, facile alkylation at N1 via either a Mitsunobu or a direct alkylation reaction and arylation at C3 via a Suzuki reaction. (C) 2011 Elsevier Ltd. All rights reserved.